Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Guilin Sanjin Pharmaceutical claims novel saponins

Jan. 12, 2012

Chinese company patents new receptor tyrosine kinase inhibitors

Jan. 12, 2012

Japanese study supports in vivo antitumor activity of Golgi-disrupting agent

Jan. 12, 2012

Adherex continues enrollment in phase II eniluracil regimen study

Jan. 11, 2012

BKM-120 assessed as monotherapy and in combination regimens in metastatic breast cancer

Jan. 11, 2012

Phase II trial investigates effects of axitinib in metastatic melanoma

Jan. 11, 2012

Novel estrogen receptor-alpha modulators prepared by Aragon Pharmaceuticals

Jan. 10, 2012

AstraZeneca patents new protein kinase inhibitors

Jan. 10, 2012

New Evestra progesterone receptor inhibitor shows potential as breast cancer therapy

Jan. 10, 2012

Phase I/II data presented on SAR-245408-based combination regimens in metastatic breast cancer

Jan. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....